Brief: LSL Pharma Group Announces An Extension Of Its Convertible Debentures Offering
08/01/2024 13:33
Jan 8 (Reuters) - LSL Pharma Group Inc LSL.V :
* LSL PHARMA GROUP ANNOUNCES AN EXTENSION OF ITS CONVERTIBLE
DEBENTURES OFFERING
* LSL PHARMA GROUP:EXTENDS TILL FEB 7, ITS BROKERED PRIVATE
PLACEMENT THROUGH ISSUANCE OF UNSECURED CONVERTIBLE DEBENTURES
AT PRICE OF $10 PER DEBENTURE
Source text for Eikon: ID:nGNX5gMdvy
Further company coverage: LSL.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LSL Pharma
See all newsBrief: LSL Pharma Group Announces CFO Transition
Canada's LSL Pharma Q2 revenue surges on acquisition boost, eye-drop launches
Brief: Lsl Pharma Group Reports Record Revenues And Second Quarter 2026 Results
Brief: LSL Pharma Group Successfully Obtained U.S. FDA Certification For The Manufacturing Of Ophthalmic Ointments For Commercialization In The United States
Brief: LSL Pharma Group Announces Closing Of The Acquisition Of Juno Otc And Final $2M Closing Of Upsized $12M Offering